NCT03872947 2025-08-03A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid TumorsToray Industries, IncPhase 1 Active not recruiting138 enrolled
NCT00352859 2014-12-30Phase IV Randomization to On-Going Treatment to Evaluate Sustained SorafenibBayerPhase 4 Terminated2 enrolled